AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...

Prostate cancer cells require large amounts of nutrients. When these run low, GCN2 signals the cells to produce more fuel.

Researchers say they have been encouraged by trials of a new process to detect prostate cancer in men. It is hoped that the ...

Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical ...

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Advanced Imaging Uncovers Hidden Metastases in High-Risk Prostate Cancer Cases Jan. 3, 2025 — A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer ...

Here the authors report the results of a phase 1 trial of PSCA-directed autologous CAR-T cells with pharmacological activation by rimiducid in patients with metastatic pancreatic or prostate cancer.